Pfizer’s Immunotherapy for Skin Cancer Gets FDA Approval – Yahoo Finance
FiercePharma |
Pfizer's Immunotherapy for Skin Cancer Gets FDA Approval
Yahoo Finance With the FDA approval, avelumab becomes the first immunotherapy option for the treatment of metastatic MCC, a rare form of skin cancer, which until now was being treated only with chemotherapy. Only less than 50% of the metastatic MCC patients survive … Pfizer, Merck KGaA score watershed FDA nod on cancer immunotherapy Bavencio FDA approves Pfizer, German Merck immunotherapy for skin cancer Pfizer (PFE) and Merck (MRK) BioPharma Unit Get FDA Approval for BAVENCIO® (Avelumab), the 1st Immunotherapy … |
